Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)

Abhishek Sharma; Sunny Goel; Carl J. Lavie; Armin Arbab-Zadeh; Debabrata Mukherjee; Jason Lazar

doi:10.1007/s11239-014-1118-x

Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)

Abhishek Sharma, Sunny Goel, Carl J. Lavie, Armin Arbab-Zadeh, Debabrata Mukherjee, Jason Lazar

School of Medicine

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Transcatheter aortic valve replacement (TAVR) has been emerged as a promising alternative for the management of patients with severe AS who otherwise are deemed inappropriate candidates for surgery. Post procedural thromboembolic events and risk of bleeding continue to be a significant challenge in managing patients who underwent TAVR. This article systematically reviews the evidence, current guidelines and upcoming studies investigating antithrombotic therapy before, during and after TAVR.

Original language	English (US)
Pages (from-to)	467-473
Number of pages	7
Journal	Journal of Thrombosis and Thrombolysis
Volume	39
Issue number	4
DOIs	https://doi.org/10.1007/s11239-014-1118-x
State	Published - May 1 2015

Keywords

Dual antiplatelet therapy (DAPT)
Transcatheter aortic valve replacement (TAVR)

ASJC Scopus subject areas

Hematology
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11239-014-1118-x

Cite this

@article{f24e8e31bb534a4cb67f1b65067324f5,

title = "Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)",

abstract = "Transcatheter aortic valve replacement (TAVR) has been emerged as a promising alternative for the management of patients with severe AS who otherwise are deemed inappropriate candidates for surgery. Post procedural thromboembolic events and risk of bleeding continue to be a significant challenge in managing patients who underwent TAVR. This article systematically reviews the evidence, current guidelines and upcoming studies investigating antithrombotic therapy before, during and after TAVR.",

keywords = "Dual antiplatelet therapy (DAPT), Transcatheter aortic valve replacement (TAVR)",

author = "Abhishek Sharma and Sunny Goel and Lavie, {Carl J.} and Armin Arbab-Zadeh and Debabrata Mukherjee and Jason Lazar",

note = "Publisher Copyright: {\textcopyright} 2014, Springer Science+Business Media New York.",

year = "2015",

month = may,

day = "1",

doi = "10.1007/s11239-014-1118-x",

language = "English (US)",

volume = "39",

pages = "467--473",

journal = "Journal of Thrombosis and Thrombolysis",

issn = "0929-5305",

publisher = "Springer Netherlands",

number = "4",

}

TY - JOUR

T1 - Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)

AU - Sharma, Abhishek

AU - Goel, Sunny

AU - Lavie, Carl J.

AU - Arbab-Zadeh, Armin

AU - Mukherjee, Debabrata

AU - Lazar, Jason

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Transcatheter aortic valve replacement (TAVR) has been emerged as a promising alternative for the management of patients with severe AS who otherwise are deemed inappropriate candidates for surgery. Post procedural thromboembolic events and risk of bleeding continue to be a significant challenge in managing patients who underwent TAVR. This article systematically reviews the evidence, current guidelines and upcoming studies investigating antithrombotic therapy before, during and after TAVR.

AB - Transcatheter aortic valve replacement (TAVR) has been emerged as a promising alternative for the management of patients with severe AS who otherwise are deemed inappropriate candidates for surgery. Post procedural thromboembolic events and risk of bleeding continue to be a significant challenge in managing patients who underwent TAVR. This article systematically reviews the evidence, current guidelines and upcoming studies investigating antithrombotic therapy before, during and after TAVR.

KW - Dual antiplatelet therapy (DAPT)

KW - Transcatheter aortic valve replacement (TAVR)

UR - http://www.scopus.com/inward/record.url?scp=84939896870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939896870&partnerID=8YFLogxK

U2 - 10.1007/s11239-014-1118-x

DO - 10.1007/s11239-014-1118-x

M3 - Article

C2 - 25103613

AN - SCOPUS:84939896870

SN - 0929-5305

VL - 39

SP - 467

EP - 473

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

IS - 4

ER -

Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this